跳至主要内容
临床试验/NCT04175054
NCT04175054撤回不适用

Training to Restore Walking and Promote Nervous System Repair in Multiple Sclerosis: RCT to Determine the Importance of Intensity

Memorial University of Newfoundland2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2030年1月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
70
试验地点
2
主要终点
Fast walking speed

研究概览

简要总结

New research in animal models of MS suggests that greater training intensity is required to restore lost functions. We have developed and tested vigorous intensity cool room treadmill training that people with MS who have fatigue and heat-sensitivity can tolerate. This study will focus on the appropriate dosage of training.

详细描述

Our previous research showed that vigorous aerobic training in a room cooled to 16°C can improve walking and measures of brain plasticity among people with MS related walking disability, especially in those who had fatigue and heat sensitivity. As a next step, we will compare our novel vigorous intensity cool room treadmill training to low intensity cool room treadmill walking and determine whether intensity is important in order to improve brain repair and restore walking among people with MS. Our first objective is to compare the effects of 12 weeks of vigorous versus low intensity training on walking. Our second objective is to determine whether treadmill training alters indicators of brain repair. We hypothesize that the cool room vigorous training will result in greater increases in walking and less fatigue, which will be sustained at follow-up. We also hypothesize that improvements will align with less brain inhibition (shortened CSP measured using Transcranial Magnetic Stimulation) and greater upregulation of the neurotrophin IGF-1.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

The outcome assessor will be blinded to group allocation, and will not be involved in conducting the training intervention.

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • people with a confirmed diagnosis of relapsing-remitting or progressive MS
  • older than 18 and less than 70 years of age
  • able to walk at least 10 meters with use of walking aids (Expanded Disability Status Scale (EDSS) <7.0)
  • must be stable without relapse for at least 90 days

排除标准

  • currently attending physical rehabilitation
  • functional community ambulators (gait speed>120 cm/s)
  • a relapse of MS

结局指标

主要结局

Fast walking speed

时间窗: 12 weeks

Gait velocity (cm/s) measured while walking at fast pace

次要结局

  • Spatiotemporal parameters of gait measured while walking at self-selected pace(Following completion of the 12-week exercise intervention and 3-months post-exercise intervention)
  • Maximal oxygen consumption during graded exercise test(Following completion of the 12-week exercise intervention and 3-months post-exercise intervention)
  • Multiple Sclerosis Impact Scale-29(Following completion of the 12-week exercise intervention and 3-months post-exercise intervention)
  • Hospital Anxiety and Depression Scale(Following completion of the 12-week exercise intervention and 3-months post-exercise intervention)
  • Fatigue Severity Scale(Following completion of the 12-week exercise intervention and 3-months post-exercise intervention)
  • Symbol Digit Modality Test(Following completion of the 12-week exercise intervention and 3-months post-exercise intervention)
  • Serum Insulin-like growth factor-1 (IGF-1)(Following completion of the 12-week exercise intervention and 3-months post-exercise intervention)
  • Transcranial Magnetic Stimulation(Following completion of the 12-week exercise intervention and 3-months post-exercise intervention)
  • Structural and functional brain changes on Magnetic Resonance Imaging (MRI)(Following completion of the 12-week exercise intervention and 3-months post-exercise intervention)
  • Montreal Cognitive Assessment(Following completion of the 12-week exercise intervention and 3-months post-exercise intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michelle Ploughman

Associate Professor of Medicine

Memorial University of Newfoundland

研究点 (2)

Loading locations...

相似试验